| AKT | Protein kinase B |
| AXL | AXL receptor tyrosine kinase |
| CAF | cancer-associated fibroblast |
| COX-2 | cyclooxygenase-2 |
| CXCL12 | C-X-C motif chemokine ligand 12 |
| CXCR4 | C-X-C chemokine receptor type 4 |
| ECM | extracellular matrix |
| EGF | epidermal growth factor |
| EGCG | epigallocatechin-3-gallate |
| EGFR | epidermal growth factor receptor |
| EMT | epithelial–mesenchymal transition |
| ERK | extracellular signal-regulated kinase |
| FAK | focal adhesion kinase |
| FGF | fibroblast growth factor |
| FGFR | fibroblast growth factor receptor |
| GAS6 | growth arrest-specific 6 |
| HGF | hepatocyte growth factor |
| HIF-1α | hypoxia-inducible factor 1 alpha |
| IGF | insulin-like growth factor |
| IGF1R | insulin-like growth factor 1 receptor |
| IL | interleukin |
| IL-1β | interleukin-1 beta |
| IL-6 | interleukin-6 |
| IL-8 | interleukin-8 |
| JAK | Janus kinase |
| JNK | c-Jun N-terminal kinase |
| MAPK | mitogen-activated protein kinase |
| MCP-1 | monocyte chemoattractant protein-1 |
| MEK | MAPK/ERK kinase |
| MET/c-MET | mesenchymal–epithelial transition factor |
| MMP | matrix metalloproteinase |
| mTOR | mechanistic target of rapamycin |
| NF-κB | nuclear factor kappa B |
| PDGF | platelet-derived growth factor |
| PDGFR | platelet-derived growth factor receptor |
| PGE2 | prostaglandin E2 |
| PI3K | phosphoinositide 3-kinase |
| Pro-EGCG | prodrug of epigallocatechin-3-gallate |
| RAS | rat sarcoma viral oncogene homolog |
| Rg3 | ginsenoside Rg3 |
| ROS | reactive oxygen species |
| RTK | receptor tyrosine kinase |
| Smad | small mothers against decapentaplegic |
| SRC | SRC proto-oncogene, non-receptor tyrosine kinase |
| STAT3 | signal transducer and activator of transcription 3 |
| TGF-β | transforming growth factor beta |
| TIMP | tissue inhibitor of metalloproteinase |
| TNF-α | tumor necrosis factor alpha |
| VEGF | vascular endothelial growth factor |
| VEGFR | vascular endothelial growth factor receptor |